Robert E. Sell, Group Chief Exec-Com, Med & Technology at Accenture plc (ACN), sold 6,500 shares at $152.53 ($994K) on 2018-04-20, disclosed to the SEC on 2018-04-23.
Seasonal sale ($994k) by Group Chief Exec-Com, Med & Technology — this insider has traded ACN in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.53 | 2,350 | $358K | 36.1% |
| 2 | $152.53 | 2,350 | $358K | 36.1% |
| 3 | $153.45 | 1,000 | $153K | 15.4% |
| 4 | $154.23 | 400 | $62K | 6.2% |
| 5 | $154.23 | 400 | $62K | 6.2% |
| Total | $152.88 avg | 6,500 |
| $994K |
| 100% |
| Filing → |
| ACN | SELL | 2017-10-03 | $469K | — | Filing → |
| ACN | SELL | 2017-06-27 | $369K | — | Filing → |
| ACN | SELL | 2017-04-28 | $329K | — | Filing → |